Premium
Do we need PD‐L1 as a biomarker for thyroid cytologic and histologic specimens?
Author(s) -
Pusztaszeri Marc P.,
Bongiovanni Massimo,
Brimo Fadi
Publication year - 2020
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22223
Subject(s) - medicine , thyroid , malignancy , pathology , cytology , thyroid carcinoma , thyroid cancer , biomarker , papillary thyroid cancer , cancer , oncology , biochemistry , chemistry
This editorial introduces the study by Dell’Aquila and colleagues in this edition of Cancer , which suggests that Programmed death‐ligand 1 (PD‐L1) expression in the thyroid gland and on thyroid liquid‐based cytology might represent a marker of malignancy that correlates with papillary thyroid carcinoma, but not with noninvasive follicular thyroid neoplasm with papillary‐like nuclear features, and discusses the potential use of PD‐L1 for thyroid lesions.